Gamma-Aminobutyric Acid

Gamma-Aminobutyric Acid

SCHEMBL2897912

C=C1N=C(c2ccccc2)OC1=O.NCCCC(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
THRB P10828 2/20 0.41
BLM P54132 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC11 Q96DB2 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC9 Q9UKV0 2/20 0.41
HDAC5 Q9UQL6 2/20 0.41
GABRR3 A8MPY1 1/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABBR2 O75899 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminocaproic Acid SCHEMBL379308 0.95 ALDH1A1 (0.44) KMT2ALMNATHRBBLMNPSR1
SCHEMBL2714415 0.81 SMN1; SMN2 (0.50) KMT2ALMNANPSR1CYP1A2ALDH1A1
SCHEMBL24534659 0.77 SMN1; SMN2 (0.47) KMT2ALMNANPSR1ALDH1A1CSNK2A2
Gamma-Aminobutyric Acid SCHEMBL5795191 0.76 HDAC3 (0.41) KMT2ALMNATHRBBLMNPSR1
Phthalic Anhydride SCHEMBL10455461 0.71 HDAC3 (0.54) KMT2ALMNATHRBBLMNPSR1
Gamma-Aminobutyric Acid SCHEMBL28119738 0.69 HDAC3 (0.60) KMT2ALMNATHRBBLMNPSR1
SCHEMBL2313102 0.68 CSNK2A2 (0.49) KMT2ALMNAALDH1A1CSNK2A2CSNK2B
SCHEMBL2313095 0.68 CSNK2A2 (0.49) KMT2ALMNAALDH1A1CSNK2A2CSNK2B
SCHEMBL24534516 0.68 GSTP1 (0.46) KMT2ATSHRALDH1A1CSNK2A2CSNK2B
Gamma-Aminobutyric Acid SCHEMBL27860343 0.68 LMNA (0.88) KMT2ALMNATHRBBLMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2224006-A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage MedImmune Limited (GB) 2010-09-01 EP disclosed
EP-1696031-B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage MEDIMMUNE LTD (GB) 2010-04-07 EP disclosed
US-20090325815-A1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RESEARCH COUNCIL (GB) 2009-12-31 US disclosed
EP-1024191-B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage MEDICAL RES COUNCIL (GB) 2008-09-10 EP disclosed
US-20080050359-A1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RESEARCH COUNCIL (GB) 2008-02-28 US disclosed
US-20070232790-A1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RESEARCH COUNCIL (GB) 2007-10-04 US disclosed
US-7195866-B2 Production of anti-self antibodies from antibody segment repertoires and displayed on phage MEDICAL RESEARCH COUNCIL (GB) 2007-03-27 US disclosed
EP-1696031-A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage Cambridge Antibody Technology Limited (GB) 2006-08-30 EP disclosed
EP-0616640-B1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RES COUNCIL (GB) 2004-09-01 EP disclosed
US-20030190674-A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage MEDICAL RESEARCH COUNCIL 2003-10-09 US disclosed
US-6555313-B1 Antibodies directed against self antigens isolated using bacteriophage display technology MEDICAL RESEARCH COUNCIL (GB) 2003-04-29 US disclosed
US-6544731-B1 Genetic engineering; binding antibodies MEDICAL RESEARCH COUNCIL (GB) 2003-04-08 US disclosed
US-6521404-B1 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface MEDICAL RESEARCH COUNCIL (GB) 2003-02-18 US disclosed
EP-1024191-A2 Production of chimeric antibodies from antibody segment repertoires and displayed on phage MEDICAL RESEARCH COUNCIL (GB) 2000-08-02 EP disclosed
EP-0605522-B1 Methods for the production of humanized antibodies MEDICAL RES COUNCIL (GB) 1999-06-23 EP disclosed
US-5885793-A Production of anti-self antibodies from antibody segment repertoires and displayed on phage MEDICAL RESEARCH COUNCIL (GB) 1999-03-23 US disclosed
EP-0616640-A1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RESEARCH COUNCIL (GB) 1994-09-28 EP disclosed
EP-0605522-A1 PRODUCTION OF CHIMERIC ANTIBODIES - A COMBINATORIAL APPROACH MEDICAL RESEARCH COUNCIL (GB) 1994-07-13 EP disclosed
WO-1993011236-A1 PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE MEDICAL RESEARCH COUNCIL (GB) 1993-06-10 WO disclosed
WO-1993006213-A1 PRODUCTION OF CHIMERIC ANTIBODIES - A COMBINATORIAL APPROACH MEDICAL RESEARCH COUNCIL (GB) 1993-04-01 WO disclosed